In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease ...

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

If tighter limits on mifepristone take effect, one immediate shift would be toward misoprostol-only protocols.

An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in ...

Two new studies have identified risk factors that may be associated with the increasing incidence of colorectal cancer among ...

Labour turmoil threatens to overshadow NHS modernisation bill as Health Secretary Wes Streeting mulls leadership bid.

At an initial visit with a patient who is postpartum, clinicians should ask questions about pregnancy-related complications ...

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in ...

Patients with mental illness seeking primary care show an elevated cardiovascular risk as per SCORE2, and targeted health ...

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with ...